ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
An RNA-Binding Protein RBMS1 Promotes Endothelial Cell Autophagy to Maintain Vascular Homeostasis and Suppress Deep Vein Thrombosis.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Deep vein thrombosis (DVT) is a prevalent vascular disorder characterized by aberrant coagulation within the deep venous system, and the roles of RNA-binding proteins (RBPs) in its pathogenesis remain largely undefined. Herein, using a murine inferior vena cava (IVC) stenosis model, we identify RNA-binding motif single-stranded interacting protein 1 (RBMS1) as a previously unrecognized regulator of DVT progression via the modulation of vascular endothelial cell (VEC) autophagy. By utilizing endothelial cell-conditional Rbms1 knockout mice, we demonstrate that RBMS1 deficiency exacerbates thrombus formation and impairs VEC function. Mechanistically, RBMS1 associates with autophagy-related 3 (ATG3) mRNA through its 3'-untranslated region (3'-UTR) and enhances its stability, thereby promoting autophagic flux in VECs. RBMS1 depletion destabilizes ATG3 mRNA, leading to suppressed autophagy and compromised endothelial homeostasis. Conversely, ATG3 overexpression rescues autophagy impairment and mitigates thrombotic phenotypes upon RBMS1 depletion. Collectively, our findings in the IVC stenosis-induced DVT model demonstrate that RBMS1 regulates ATG3 to maintain vascular endothelial integrity, providing a mechanistic basis for further evaluation of RBMS1 in DVT intervention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.